Valuation: Illumina, Inc.

Market Cap 28.24B 24.75B 22.88B 21.04B 39.7B 2,723B 40.34B 274B 107B 1,332B 106B 104B 4,591B P/E 2026 *
39.8x
P/E 2027 * 32.8x
Enterprise Value 28.73B 25.18B 23.28B 21.41B 40.4B 2,771B 41.04B 278B 109B 1,356B 108B 106B 4,671B EV / Sales 2026 *
6.29x
EV / Sales 2027 * 5.8x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.06%
1 week-2.90%
Current month+5.03%
1 month+14.05%
3 months+37.31%
6 months+30.38%
Current year+40.81%
1 week 183.74
Extreme 183.745
194.18
1 month 158.91
Extreme 158.91
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

142 0.0001%
30/06/26 Free

Director

167 0.0001%
30/06/26
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-1.06%-2.90%+92.09%+0.08% 28.24B
-1.17%-0.16%+26.88%-1.74% 198B
-1.33%+1.03%+5.82%-17.54% 144B
+2.24%-13.18%-31.90%+0.99% 122B
-0.59%-2.23%-57.77%-16.37% 65.44B
-0.85%-7.82%+11.13%-7.23% 49.36B
+0.65%+2.20%-23.34%-30.88% 44.74B
-0.91%-3.00%+14.27%+5.83% 37.13B
-3.10%-5.02%+24.35%+27.66% 36.23B
-0.19%-2.58%-23.00%-8.92% 28.7B
Average -0.61%-2.71%+3.85%-4.81% 75.43B
Weighted average by Cap. -0.46%-2.59%+1.77%-6.10%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.7B 3.41B 6.43B 441B 6.53B 44.28B 17.36B 216B 17.16B 16.79B 743B 4.83B 4.23B 3.91B 3.6B 6.79B 466B 6.9B 46.8B 18.35B 228B 18.14B 17.74B 785B
Net income 723M 634M 586M 539M 1.02B 69.76B 1.03B 7.01B 2.75B 34.14B 2.72B 2.66B 118B 871M 764M 706M 649M 1.23B 84.04B 1.24B 8.44B 3.31B 41.12B 3.27B 3.2B 142B
Net Debt 492M 431M 398M 366M 691M 47.4B 702M 4.76B 1.87B 23.19B 1.85B 1.81B 79.9B -222M -194M -179M -165M -311M -21.36B -316M -2.15B -841M -10.45B -832M -814M -36.01B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
21/07/26 $184.68 -1.06% 1,497,007
17/07/26 $186.65 -1.89% 1,251,212
16/07/26 $190.25 +1.66% 1,140,846
15/07/26 $187.15 -2.12% 1,782,478
14/07/26 $191.20 +0.61% 1,994,908
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
184.68USD
Average target price
169.47USD
Spread / Average Target
-8.23%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock